{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:05:00Z","timestamp":1789538700018,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate peripheral metabolic alterations in patients with schizophrenia using a two-stage metabolomic workflow of untargeted analysis and targeted re-analysis,explore the associated metabolic pathways, identify potential peripheral metabolic biomarkers, and elucidate the underlying metabolic dysregulation mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma samples were collected from 24 schizophrenia patients and 10 healthy controls for non-derivatized targeted metabolomics analysis. Differential metabolites were identified and visualized using box plots. Hierarchical clustering analysis was performed to evaluate expression pattern differences across samples, and KEGG pathway enrichment analysis was conducted to map the involved biological pathways. False discovery rate (FDR) correction was applied for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 21 quantified metabolites, four exhibited significant differences after FDR correction (FDR &amp;lt; 0.05). \u03b1-Ketoglutarate was significantly elevated in the patient group, whereas succinic acid, tryptamine, and amino butyric acid were significantly reduced. The opposite variations of \u03b1-ketoglutarate and succinic acid suggest a peripheral TCA cycle metabolic bottleneck. Hierarchical clustering based on these four metabolites effectively distinguished patients from healthy controls. KEGG enrichment demonstrated that these metabolites converged predominantly on amino acid metabolism, energy metabolism, and most notably the GABAergic synapse pathway, offering peripheral evidence supporting the core position of GABAergic dysfunction in schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Schizophrenia patients display significant peripheral metabolic disturbances characterized by dysregulated amino acid metabolism, synaptic transmission abnormalities, and energy metabolism imbalance. The four-metabolite panel (\u03b1-ketoglutarate, succinic acid, tryptamine, and amino butyric acid) may provide experimental basis for further mechanistic research and therapeutic development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1935417","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:32:54Z","timestamp":1789536774000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral neurotransmitter metabolic signatures in schizophrenia: a targeted metabolomics study"],"prefix":"10.3389","volume":"17","author":[{"given":"Bing","family":"Han","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[{"name":"Health Service Department, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baie","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Health Service Department, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzi","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiology, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, No. 984 Hospital of the PLA","place":["Beijing, China"]},{"name":"Psychiatry and Psychology Center, No. 984 Hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, No. 984 Hospital of the PLA","place":["Beijing, China"]},{"name":"Combat Trauma Center, No. 984 hospital of the PLA","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041906","article-title":"Emerging neurobiological and therapeutic insights into schizophrenia: A comprehensive review","volume":"27","author":"Oatu","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199814","article-title":"The etiological role of impaired neurogenesis in schizophrenia: Interactions with inflammatory, microbiome and hormonal signaling","volume":"26","author":"So","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1740079","article-title":"Bioenergetic impairment in schizophrenia: Role of mitochondrial signaling in synaptic dysfunction - a systematic review","volume":"14","author":"Ricci","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1750377","article-title":"Microbiome driven modulation of neurotransmitters: Implications for neurotransmission and mood disorders","volume":"17","author":"Sivamaruthi","year":"2026","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.5c00892","article-title":"Psychedelic modulation of excitation\/inhibition balance: A dual-phase neurodevelopmental model","volume":"17","author":"Kandilakis","year":"2026","journal-title":"ACS Chem Neurosci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12035-025-05538-5","article-title":"Production, mechanisms, and therapeutic strategies of tryptophan metabolites in CNS diseases","volume":"63","author":"Shi","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00118","article-title":"GABAergic mechanisms in schizophrenia: Linking postmortem and in vivo studies","volume":"8","author":"de Jonge","year":"2017","journal-title":"Front Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B9","unstructured":"Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations - Pubmed"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.1038\/s41598-025-30521-4","article-title":"Cerebrospinal fluid and plasma metabolites in Parkinson\u2019s disease: A Mendelian randomization study","volume":"16","author":"Wang","year":"2026","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042294","article-title":"Association of blood metabolomics biomarkers with brain metabolites and patient-reported outcomes as a new approach in individualized diagnosis of schizophrenia","volume":"25","author":"Krzy\u015bciak","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-026-08441-y","article-title":"Untargeted metabolomics reveals plasma metabolic dysregulation in schizophrenia","author":"Han","year":"2026","journal-title":"BMC Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-023-10050-x","article-title":"Characteristics of international assaultive psychiatric patients: Review of published findings, 2017-2022","volume":"94","author":"Flannery","year":"2023","journal-title":"Psychiatr Q"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2026.120887","article-title":"Multi-omics biomarkers in psychiatric disorders diagnosis and stratification","volume":"585","author":"Khatami","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70029","article-title":"The glutamate\/GABA-glutamine cycle: Insights, updates, and advances","volume":"169","author":"Andersen","year":"2025","journal-title":"J Neurochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102663","article-title":"The physiological metabolite \u03b1-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.10.007","article-title":"Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients","volume":"21","author":"Bubber","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12916-025-04218-4","article-title":"Metformin-improved cognitive impairment in patients with schizophrenia is correlated with activation of tricarboxylic acid cycle and restored functional connectivity of hippocampus","volume":"23","author":"Cai","year":"2025","journal-title":"BMC Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/nu18030507","article-title":"Serotonin, kynurenine, and indole pathways of tryptophan metabolism in humans in health and disease","volume":"18","author":"Hole\u010dek","year":"2026","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.05.021","article-title":"The kynurenine pathway in traumatic brain injury: Implications for psychiatric outcomes","volume":"91","author":"Meier","year":"2022","journal-title":"Biol Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2026.121858","article-title":"Integrative multi-kingdom gut microbiome analysis uncovers clinical signatures of major depressive disorder","volume":"408","author":"Chen","year":"2026","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2009.33","article-title":"Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia","volume":"15","author":"Yao","year":"2010","journal-title":"Mol Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1161608","article-title":"Beyond the \u03b3-aminobutyric acid hypothesis of schizophrenia","volume":"17","author":"Fujihara","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1762930","article-title":"From synapse to system: Mechanistic pathways of neural signaling dysfunction in psychiatric disorders","volume":"14","author":"Gupta","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.34133\/research.1142","article-title":"The Brain-Gut Health Initiative (BIGHI): A prospective cohort on psychiatric disorders in China","volume":"9","author":"Wu","year":"2026","journal-title":"Res (Wash D C)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071593","article-title":"Mechanisms of synaptic vesicle exo- and endocytosis","volume":"10","author":"Mochida","year":"2022","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11920-016-0710-5","article-title":"Dysregulations of synaptic vesicle trafficking in schizophrenia","volume":"18","author":"Egbujo","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202517087","article-title":"Dissecting the ecological structure of health and disease in the global gut microbiome","volume":"13","author":"Zhu","year":"2026","journal-title":"Adv Sci (Weinh)"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1935417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:32:57Z","timestamp":1789536777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1935417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":29,"alternative-id":["10.3389\/fpsyt.2026.1935417"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1935417","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1935417"}}